Citigroup
CERO

Citigroup’s CERo Therapeutics CERO Stock Holding History

Citigroup’s Portfolio CERO Stock Details CERO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-968
Closed -$4.93K – 6546
2025
Q3 		$4.93K Buy
+968
New +$7.12K ﹤0.01% 5235

Citigroup's CERO Position: Q4 2025 in Review

Citigroup sold out of CERo Therapeutics (CERO) in Q4 2025, closing a stake of 968 shares — an estimated $4.93K sold.

Citigroup first reported a position in CERO in Q3 2025 and held it in 1 quarter. The position peaked at $4.93K in Q3 2025. 0 funds tracked by Wall St. Rank hold CERO as of Q4 2025.

  • Citigroup reported no remaining CERo Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Citigroup sold 968 CERo Therapeutics shares in Q4 2025, an estimated $4.93K.
  • Citigroup first reported a position in CERo Therapeutics in Q3 2025 and held it in 1 quarter.
  • Citigroup's CERo Therapeutics position peaked at $4.93K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held CERo Therapeutics as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.